News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nanosonics.
RELATED STOCKHEAD STORIES
Health & Biotech
ScoPo’s Powerplays: IDT wins big on COVID vaccines, but Healthcare IPOs look exhausted
Health & Biotech
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
Health & Biotech
ScoPo’s Powerplays: Investors become a ‘little more picky’ as markets continue to push ever higher
News
Here are the top ASX large cap movers for Tuesday
Health & Biotech
ScoPo’s Powerplays: Reopening brings previously neglected health stocks into play
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
Health & Biotech
ScoPo’s Powerplays: Recent price swings uncovered hidden gems and buying opportunities in healthcare
Health & Biotech
ScoPo’s Powerplays: ‘Ansell is a buy’, while all eyes are on ImpediMed’s upcoming publication
News
Here are the top ASX large cap movers for Tuesday
Health & Biotech
ASX Health Stocks: Nanosonics jumps almost 20% as revenue momentum picks up steam
News
ASX Small Cap Lunch Wrap: Who wants to ruin Father’s Day this year?
News
10 at 10: These ASX stocks have hit a home run this morning
Health & Biotech
ScoPo’s Powerplays: Quality names continue to catch a bid as earnings roll in
Health & Biotech
ScoPo’s Powerplays: ASX biotech IPOs show ‘money is out there’; Virtus to benefit from rise in IVF
Health & Biotech
ScoPo’s Powerplays: Quarterlies to dictate price moves, as Nanosonics and Neuren come into play
Health & Biotech
ScoPo’s Powerplays: ‘Go long equities’ as Nanosonics, Antisense, Volpara to benefit from V-shaped recovery
News